Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | CB307 |
Trade Name | |
Synonyms | CB-307|CB 307 |
Drug Descriptions |
CB307 is a tri-specific humabody targeting TNFRSF9 (CD137), prostate-specific membrane antigen (PSMA), and human serum albumin (HSA), potentially enhancing immune cell activity in the presence of PSMA-positive tumor cells (Cancer Res 2022;82(12_Suppl):Abstract nr 2877). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C180592 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CB307 | CB307 | 0 | 1 |